Shopping Cart
- Remove All
- Your shopping cart is currently empty
CT-721 is a potent, time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase, exhibiting anti-chronic myeloid leukemia (CML) activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.871 € | 8-10 weeks | |
50 mg | 2.451 € | 8-10 weeks | |
100 mg | 3.230 € | 8-10 weeks |
Description | CT-721 is a potent, time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase, exhibiting anti-chronic myeloid leukemia (CML) activity. |
Targets&IC50 | BCR-ABL (WT):21.3 nM |
Molecular Weight | 525.04 |
Formula | C30H29ClN6O |
Cas No. | 1388710-60-8 |
Relative Density. | 1.32 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.